NMS Group
Giulia Caputo currently serves as an Analytical Scientist at NMS Group - Nerviano Medical Sciences since 2020. Prior experience includes roles at Chiesi Italia, where responsibilities involved characterizing impurities and degradants using advanced analytical techniques and supporting drug discovery and development efforts. Giulia began in the pharmaceutical sector with an internship at Farmacia De Donno and gained expertise through an organic synthesis internship at Université de Reims Champagne-Ardenne. Education credentials include a Master's degree in Pharmaceutical Chemistry and Technology from Università degli Studi 'Gabriele d'Annunzio' di Chieti, and a professional qualification as a pharmacist. Additional academic accomplishments feature participation in the Erasmus Plus program in France and a scientific high school diploma from Liceo Classico Statale "F. Capece."
This person is not in any offices
NMS Group
NMS Group S.p.A. is the largest company in Italy committed in innovation and oncology R&D. With 420 total employees, NMS Group employs over 200 qualified researchers involved in research and development, from 'target validation' to phase II clinical trials. NMS Group S.p.A. is the only company in Italy able to manage the entire integrated chain of the research and development path: from pre-clinical phase of research, to First-Time-In-Man of clinical phase, up to production and packaging of the finished drug. The Group also provides services of Research and Production addressed to local and international markets through three different companies: Accelera, one of the few companies engaged in preclinical research in Italy; Clioss engaged in clinical development starting from First-Time-In-Man and Nerpharma, dealing with activities from formulation to production of the active principle.